Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has executed a credentialing agreement with Prime Health Services, Inc. (Prime Health), a managed care company that offers a full spectrum of services, including a Preferred Provider Organization (PPO), for the inclusion of Rosetta Genomics' miRview(®) mets(2) test in Prime Health's covered products and services.
The agreement with Prime Health is the first credentialing agreement executed between Rosetta Genomics and a U.S. PPO, ...
read more